23 Drug Makers to Invest US$1 Billion in “AMR Action Fund” to Develop 2-4 New Antibiotics by 2030

Representatives from Japanese Companies Taking Part in the AMR Action Fund Twenty-three drug makers from Japan, the US, and Europe will establish a fund to support investment in and development of antibiotics as a measure against antimicrobial resistance (AMR). They...read more